Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
5-
EC/CAS
107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
1-
EC/CAS
27138-31-4
Name of the chemical
DPGDB, Oxydipropyl dibenzoate
Concentration
1-
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-
EC/CAS
9004-58-4
Name of the chemical
ethylhydroxyethylcellulose
Concentration
0.5-
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
0.5-1.5
General Information
Revision date
2016-11-07
Product name
3M(TM) Fire Barrier Sealant FD 150+, Limestone
1.2.1 Relevant identified uses
Passive Fire Protection
supplier name
3M
Manufacturer Name
3M
Emergency telephone
1-800-364-3577
Icons in SDS
Company Information
company name
3M
Section 2
2.1 Classification of the substance or mixture
Skin Corrosion/Irritation: Category 2. Carcinogenicity: Category 1A. Specific Target Organ Toxicity (single exposure): Category 1.
Hazard pictograms
Exclamation mark | Page 1
Hazard statements
Causes skin irritation. May cause cancer. Causes damage to organs: cardiovascular system | nervous system | kidney/urinary tract | respiratory system |
Precautionary statements
General: Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Wear protective gloves. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.
Response
IF ON SKIN: Wash with plenty of soap and water. If skin irritation occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse. IF exposed: Call a POISON CENTER or doctor/physician. Specific treatment (see Notes to Physician on this label).
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with applicable local/regional/national/international regulations. Notes to Physician: This product contains ethylene glycol. If there 1s reasonable suspicion of ethylene glycol poisoning, intravenous (IV) administration with either fomepizole (preferred) or ethanol (if fomepizole is unavailable) should be considered as part of the medical management.
2.3 Other hazards
None. 11% of the mixture consists of ingredients of unknown acute oral toxicity. 11% of the mixture consists of ingredients of unknown acute dermal toxicity. 9% of the mixture consists of ingredients of unknown acute inhalation toxicity.
